| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |